Search
for
Sort by
Research 571–600 of 1000+
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Meibomian Gland Dysfunction: Endocrine Aspects
- Bilateral adrenalectomy induces early onset of summer fur growth in mink (Mustela vison)
- Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome
- The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
- Ovarian Stromal Hyperthecosis and Hyperandrogenemia Refractory to Hormonal Suppression
- Bibliometric Study of Adaptogens in Dermatology: Pharmacophylogeny, Phytochemistry, and Pharmacological Mechanisms
- Potential Role of Cinnamon (<i>Cinnamomum verum</i>) to Reduce the Risk of Polycystic Ovary Syndrome by Managing the Obesity: A Review
- Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
- Polycystic Ovary Syndrome Phenotypes and Infertility Treatment
- Prolonged use of finasteride-induced gonadal sex steroids alterations, DNA damage and menstrual bleeding in women
- Neuroendocrine, Neurotransmitter, and Gut Microbiota Imbalance Contributing to Potential Psychiatric Disorder Prevalence in PCOS
- Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Polycystic ovary syndrome: Diagnosis and management
- Parity-related variation in cortisol concentrations in hair during pregnancy and in the postpartum period: a prospective cohort study
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Hirsutism-A Comprehensive Update of Embryology, Aetiopathogenesis and Therapeutic Approach
- Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Quercetin and polycystic ovary syndrome
- Acne Syndromes and Mosaicism
- Diagnosis of polycystic ovaries syndrome: establishment of reference values of nine hormones on Maglumi X- 8
- How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?
- Is dehydroepiandrosterone a hormone?
- Anti-androgen therapy in dermatology: a review
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*